Actively Recruiting

Phase Not Applicable
Age: 65Years - 90Years
All Genders
NCT06952387

PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery

Led by Nanfang Hospital, Southern Medical University · Updated on 2025-07-14

1624

Participants Needed

7

Research Sites

182 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

High-risk populations, particularly elderly individuals and patients with cardiovascular comorbidities, exhibit markedly elevated incidences of postoperative myocardial injury (MINS), acute kidney injury (AKI), and mortality. Intraoperative hypotension (IOH), a pervasive clinical phenomenon affecting 40%-90% of surgical cases, Substantial observational evidence links IOH severity/duration to ischemic organ injuries (MINS, AKI) and long-term morbidity.Nevertheless, inherent limitations of observational designs-particularly residual confounding-preclude definitive causal inferences. Notably, randomized controlled trials (RCTs) investigating goal-directed hemodynamic interventions demonstrate inconsistent clinical benefits, underscoring the imperative to clarify causal mechanisms between IOH and organ injury. This causal ambiguity arises from two unresolved scientific questions: (1) Threshold personalization deficit; (2) Therapeutic strategy limitations. In light of current evidence, perioperative hypotension management demands personalized strategies, the investigators propose a multicenter randomized controlled trial (RCT) that aims to clarify the clinical benefits of individualized blood pressure management.

CONDITIONS

Official Title

PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery

Who Can Participate

Age: 65Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 65 to 90 years
  • Scheduled for elective major non-cardiac surgery under general anesthesia lasting 2 hours or more
  • Expected postoperative hospital stay of 2 days or more
  • High cardiovascular risk with at least one of the following: history of stroke, coronary artery disease, congestive heart failure, peripheral arterial disease
  • Preoperative brain natriuretic peptide (BNP) ≥ 92 mg/L or N-terminal pro-brain natriuretic peptide (NT-proBNP) ≥ 300 ng/L
  • Preoperative cardiac troponin (cTn) or high-sensitivity cardiac troponin (hs-cTn) above the upper reference limit
  • Hypertension requiring medication
  • Diabetes requiring medication
  • History of chronic kidney disease
  • Continuous smoking for 2 years or more, with interruptions less than one month before admission
  • Hypercholesterolemia
  • History of transient ischemic attack
Not Eligible

You will not qualify if you...

  • Refusal to participate
  • Unable to communicate preoperatively due to coma, profound dementia, or language barrier
  • Severe uncontrolled hypertension before surgery (systolic BP ≥ 180 mmHg, diastolic BP ≥ 110 mmHg)
  • Severe liver dysfunction (Child-Pugh Class C)
  • Severe kidney dysfunction requiring preoperative dialysis
  • ASA physical status ≥ V
  • Expected lifespan ≤ 24 hours
  • Unstable cardiovascular conditions including acute coronary syndrome, decompensated heart failure, severe arrhythmias, severe valvular heart disease
  • Scheduled for neurosurgery, transplantation, or vascular surgery
  • Urgent surgery
  • Diagnosed with sepsis or septic shock before surgery
  • Requiring vasopressor treatment before surgery
  • Unable to complete 24-hour automated blood pressure monitoring
  • Currently participating in another interventional study
  • Any condition deemed ineligible by clinicians

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Guangzhou First People's Hospital

Guangzhou, Guangdong, China, 510180

Active, Not Recruiting

2

Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, China, 510515

Actively Recruiting

3

The Affiliated Panyu Central Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China, 511431

Actively Recruiting

4

The Third People's Hospital of Shenzhen

Shenzhen, Guangdong, China, 518112

Not Yet Recruiting

5

The Fifth Affiliated Hospital of Sun Yat-sen University

Zhuhai, Guangdong, China, 519000

Not Yet Recruiting

6

The First Affiliated Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, China, 710061

Not Yet Recruiting

7

Sir Run Run Shaw Hospital

Hangzhou, Zhejiang, China, 310016

Not Yet Recruiting

Loading map...

Research Team

K

Ke-Xuan Liu, MD

CONTACT

S

Shuang-Jie Cao, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here